Clinical Trials Browser

Phase 4 × Carcinoma, Medullary × vandetanib × Clear all

NCT01496313 2025-10-03

To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer

Phase 4 Completed

81 enrolled 15 charts

Neoplasm Metastasis, Thyroid Neoplasms, Carcinoma, Medullary